Skip to main content

Cardiac Rehab Lowers Risk for Death After Coronary Artery Bypass Grafting

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 2, 2023 -- Cardiac rehabilitation (CR) is associated with lower two-year mortality following coronary artery bypass grafting (CABG), according to a study published online June 29 in the Annals of Thoracic Surgery.

Tyler M. Bauer, M.D., from the University of Michigan in Ann Arbor, and colleagues linked Medicare fee-for-service claims to surgical data for 6,412 patients discharged alive after isolated CABG (Jan. 1, 2015, through Sept. 30, 2019). Death within two years of discharge was compared for patients using CR versus those without CR.

The researchers found that 60.0 percent of patients were enrolled in CR for an average of 23.2 sessions, with 12.0 percent completing all recommended 36 sessions. Older age, discharge to home (versus extended care facility), and shorter length of stay were predictors for postdischarge CR use. There was a significant reduction in two-year mortality seen for CR users versus CR nonusers (unadjusted: 9.4 percent reduction; inverse probability treatment weighting: 4.8 percent reduction).

"These data suggest that CR use is associated with lower two-year mortality," the authors write. "Future quality initiatives should consider identifying and addressing root causes of poor CR enrollment and completion."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Prevalence of Cardiovascular Risk Factors, Diseases Set to Increase

THURSDAY, June 6, 2024 -- The prevalence of cardiovascular risk factors and diseases will increase through 2050, and the associated economic burden is also projected to increase...

Noncontact Facial Infrared Thermography Model Can Predict Coronary Artery Disease

WEDNESDAY, June 5, 2024 -- A noncontact facial infrared thermography (IRT) machine learning model can predict coronary artery disease (CAD), according to a study published online...

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.